177 related articles for article (PubMed ID: 28808656)
21. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
23. [Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngeal squamous cell carcinoma].
Liu Y; Li G; Su ZW; Qiu YZ; Zhang X; Yu CY; Zhou XJ; Ren SL; Huang DH; Tian YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):111-5. PubMed ID: 23710918
[TBL] [Abstract][Full Text] [Related]
24. Expression profile analysis identifies the long non-coding RNA landscape and the potential carcinogenic functions of LINC00668 in laryngeal squamous cell carcinoma.
Zhao L; Cao H; Chi W; Meng W; Cui W; Guo W; Wang B
Gene; 2019 Mar; 687():47-55. PubMed ID: 30415008
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
[TBL] [Abstract][Full Text] [Related]
26. ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis.
Li M; Tian L; Yao H; Lu J; Ge J; Guo Y; Liu M; Xiao H
Oncol Rep; 2014 Jun; 31(6):2676-82. PubMed ID: 24788532
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.
Liu TR; Xu LH; Yang AK; Zhong Q; Song M; Li MZ; Hu LJ; Chen FJ; Hu ZD; Han P; Zeng MS
PLoS One; 2012; 7(7):e40704. PubMed ID: 22815795
[TBL] [Abstract][Full Text] [Related]
28. IQGAP1 silencing suppresses the malignant characteristics of laryngeal squamous cell carcinoma cells.
Wang X; He C; Li C; Ren B; Deng Q; Gao W; Wang B
Int J Biol Markers; 2018 Jan; 33(1):73-78. PubMed ID: 28708206
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
30. [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
Hu A; Jin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):788-92. PubMed ID: 23259291
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA biomarker for human laryngeal squamous cell carcinoma prognosis.
Chen J; Shen Z; Deng H; Zhou W; Liao Q; Mu Y
Gene; 2018 Sep; 671():96-102. PubMed ID: 29775753
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.
Ekizoglu S; Seven D; Ulutin T; Guliyev J; Buyru N
BMC Cancer; 2018 Apr; 18(1):477. PubMed ID: 29703252
[TBL] [Abstract][Full Text] [Related]
33. [The expression of long non-coding RNA LINC00261 in laryngeal carcinoma tissue and their clinical significance].
Zhang CM; Gao W; Wu YY; Zhao QL; Chen B; Liu QQ; Li WY; Wen SX; Wang BQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):68-71. PubMed ID: 29774690
[No Abstract] [Full Text] [Related]
34. [The mutation and expression of MUS81 gene in laryngeal squamous cell carcinoma].
Li C; Wang S; Yuan H; Li W; Li Z; Li X; Guo X; Li F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):560-5. PubMed ID: 18841572
[TBL] [Abstract][Full Text] [Related]
35. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
[TBL] [Abstract][Full Text] [Related]
36. The underlying molecular mechanism and identification of transcription factor markers for laryngeal squamous cell carcinoma.
Mo BY; Li GS; Huang SN; He WY; Xie LY; Wei ZX; Su YS; Liang Y; Yang L; Ye C; Dai WB; Ruan L
Bioengineered; 2021 Dec; 12(1):208-224. PubMed ID: 33315534
[TBL] [Abstract][Full Text] [Related]
37. [Expression of integrin-linked kinase is closely correlated with laryngeal squamous cell carcinomas].
Wu C; Zhai N; Guan C; Ji W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(9):393-5. PubMed ID: 16836071
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma.
Zhang H; Liu X; Chen L; Cai L; Li N; Zhu P; Chen J; Song X; Li G
Oncotarget; 2017 Jan; 8(2):3471-3480. PubMed ID: 27966448
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
[TBL] [Abstract][Full Text] [Related]
40. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas.
Cao XL; Xu RJ; Zheng YY; Liu J; Teng YS; Li Y; Zhu J
Asian Pac J Cancer Prev; 2011; 12(12):3245-9. PubMed ID: 22471461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
